Pregnancy, Buprenorphine, and a Request for Silence
Renata, 34, is 22 weeks pregnant with opioid use disorder and has been on buprenorphine/naloxone 16/4 mg for 14 months through a telehealth prescriber. She reports two weeks of nightly flashbacks to a 2019 assault, sleeps three to four hours, and has stopped attending prenatal appointments since a CPS referral involving her two older children, who are in kinship care with her aunt. Her urine at 8 weeks was positive for fentanyl; the last four monthly urines are negative. She is staying with a friend and paying $200 a month; custody paperwork is unresolved. She asks you not to tell her OB that she "sometimes takes two doses in one day when the cravings get bad," and asks whether she should taper off the medication before the baby is born "so the baby isn't hooked."
1. How do you answer the taper question and the double-dosing disclosure?
Read the worked answer
On tapering: answer directly and without hedging. Current guidance is that abrupt tapering or discontinuation of buprenorphine in pregnancy is not recommended - it risks withdrawal in utero, fetal distress, preterm labor, and return to illicit use, which carries the greatest risk to both patients. The medication is the protective factor here, not the problem. Neonatal opioid withdrawal syndrome is treatable and manageable in a hospital with a nursery prepared for it; relapse and fentanyl exposure are not reliably manageable. Name that trade-off explicitly.
On double-dosing: this is clinically important and must reach the prescriber, not be buried. Explain why: dose fluctuations, diversion risk, and prenatal planning all depend on an accurate history. Blood levels and dose adjustments in the third trimester are common as metabolism changes.
On "don't tell my OB": do not promise what you may not be able to keep, and do not simply override her. Explore her fear - likely CPS, judgment, or losing the baby. Offer the preferred route: she tells the OB and prescriber herself with you present, or you make a coordinated call with her consent. If she refuses, clarify the limits of your confidentiality in advance, in plain language, before the conversation ends. Document the discussion, her choice, and the rationale.
2. She has PTSD symptoms, unstable housing, and a pregnancy. How do you sequence co-occurring treatment?
Read the worked answer
Sequencing here is not "sobriety first, trauma later." The evidence supports integrated, concurrent care, with stabilization prioritized rather than a long delay.
Immediate (weeks 1–2): safety, housing stability, sleep, and re-engagement with prenatal care. Untreated insomnia and hyperarousal are relapse risks in their own right. Coordinate with the prescriber on the double-dosing and third-trimester dose review.
Short term (weeks 2–8): begin trauma-informed, present-focused work - psychoeducation about PTSD, grounding and affect-regulation skills, and sleep intervention. Do not require her to narrate the 2019 assault to get symptom relief; stabilization skills come first. Refer for trauma-focused therapy (CPT, PE, or TF-CBT-adapted approaches) with a clinician experienced in pregnancy; exposure-based work is not contraindicated in pregnancy but requires consent and coordination with the OB.
Concurrent: continue medication for opioid use disorder without interruption; address housing and custody stressors with case management rather than treating them as background noise.
Postpartum planning, starting now (around week 30): the highest-risk period is delivery and the following months - pain management plan documented, breastfeeding guidance, newborn observation, increased support density, and postpartum mental health monitoring. Do not discharge her at delivery; that is where continuity breaks for this population.
3. What is your approach to CPS, the OB, and information sharing, given her custody situation?
Read the worked answer
Her fear is rational, and the response is transparency plus maximum client control over disclosure.
- Clarify the ground rules up front: what you must report (state-specific: suspected child abuse or neglect, and any imminent risk to a child), what you may share only with written consent, and how 42 CFR Part 2 constrains opioid treatment record disclosure even with a subpoena. Say this in plain language before she discloses anything further.
- Do not become an informal CPS investigator. Your role is treatment; coordinate, do not surveil. Only report what statute requires and document the basis.
- Build a consented release network: OB, buprenorphine prescriber, case manager, and CPS worker. Offer to attend the prenatal visit with her or to make the call together - the goal is re-engagement with prenatal care, which has already lapsed and is the most urgent gap.
- Prepare a written plan for the birth: who cares for the older children, what the hospital should know, what happens at discharge, and who she calls if she relapses. Presenting a plan tends to reduce CPS escalation more than assurances do.
- Custody advocacy: connect her with legal aid or a family defense program; unresolved custody paperwork is a concrete stressor that can be worked.
Document disclosures, consents, refusals, and your reasoning. Where you must act without consent, tell her first whenever it is safe to do so.